M1FG
ANIP icon

Mach-1 Financial Group’s ANI Pharmaceuticals ANIP Stock Holding History

Mach-1 Financial Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,508
Closed -$494K – 227
2023
Q3 		$494K Sell
8,508
-822
-9% -$47.4K 0.2% 123
2023
Q2 		$502K Buy
+9,330
New +$414K 0.14% 147

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mach-1 Financial Group's ANIP Position: Q4 2023 in Review

Mach-1 Financial Group sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 8,508 shares — an estimated $494K sold.

Mach-1 Financial Group first reported a position in ANIP in Q2 2023 and held it in 2 quarters. The position peaked at $502K in Q2 2023. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • Mach-1 Financial Group reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Mach-1 Financial Group sold 8,508 ANI Pharmaceuticals shares in Q4 2023, an estimated $494K.
  • Mach-1 Financial Group first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 2 quarters.
  • Mach-1 Financial Group's ANI Pharmaceuticals position peaked at $502K in Q2 2023.
  • 181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on Mach-1 Financial Group's 13F filing for Q4 2023, filed 5 Feb 2024.